Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1991-09-27
1993-12-21
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514181, 514415, 514843, A61K 3156, A61K 31405
Patent
active
052721418
ABSTRACT:
The present invention relates to a drug for human use, having contraceptive and menstrual cycle controlling properties, characterized in that the drug comprises N-acetyl-5-methoxytryptamine or melatonin, in a dose of 100-200 mg per day, N-acetyl-2-bromo-5-methoxytryptamine or 2-bromomelatonin in a dose of 25-50 mg per day, N-acetyl-2-iodo-5-methoxytryptamine or 2-iodomelatonin, in a dose of 20-40 mgs per day, in association with a progestine compound. The administration is carried out for 23 days, by using an association of 2-iodomelatonin and/or melatonin and/or 2-bromomelatonin and a progestinic compound, followed by 5 days in which only 2-iodomelatonin and/or melatonin and/or 2-bromomelatonin is administered; the drug having oncostatic preventive and therapeutic properties, in mammary tumours and melanomas, characterized by the use of 2-iodomelatonin, melatonin and 2-bromomelatonin respectively with doses of 20-40 mgs., 100-200 mgs., 25-50 mg per day; and the drug having moreover antikinetosic properties, and being characterized by the use of 2-iodomelatonin in a dose per day of 2.5 mg.; melatonin, in a dose per day of 10 mg and 2-bromomelatonin in a dose per day of 3.5 mg, either individually and/or in association with the acetyl coenzyme A-(AcCoA), in a dose of 8-10 mg per day.
REFERENCES:
patent: 4855305 (1989-08-01), Cohen
Di Bella Luigi
Duranti Ermanno
Fraschini Franco
Lagguzzi Aldo
Stankov Bojidar
Jordan Kimberly R.
Waddell Frederick E.
LandOfFree
Contraceptive and menstrual cycle controlling drug having oncost does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contraceptive and menstrual cycle controlling drug having oncost, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contraceptive and menstrual cycle controlling drug having oncost will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-309120